1,3,8-TRIAZASPIRO(4.5)DECAN-4-ON E DERIVATIVES USEFUL FOR THE TREATMENT OF ORL-1 RECEPTOR MEDIATED DISORDERS

Details for Australian Patent Application No. 2002252596 (hide)

Owner ORTHO-MCNEIL PHARMACEUTICAL, INC.

Inventors PAN, Kevin; REITZ, Allen, B.; JORDAN,, Alfonzo

Pub. Number AU-A-2002252596

PCT Pub. Number WO2002/083673

Priority 60/282,722 10.04.01 US

Filing date 5 April 2002

Wipo publication date 28 October 2002

International Classifications

C07D 471/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002252596

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252597-PORTABLE CLEANING ASSEMBLY

2002252595-INJECTION SEEDED F2 LASER WITH PRE-INJECTED FILTER